An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment

SIMPLE SUMMARY: One of the important efforts in the treatment of cancers is to achieve targeted drug delivery by nanocarriers to be more effective and reduce adverse effects. However, due to the adverse responses of nanocarriers in clinical trials due to the very weak EPR effects, doubts have been r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharifi, Majid, Cho, William C., Ansariesfahani, Asal, Tarharoudi, Rahil, Malekisarvar, Hedyeh, Sari, Soyar, Bloukh, Samir Haj, Edis, Zehra, Amin, Mohamadreza, Gleghorn, Jason P., Hagen, Timo L. M. ten, Falahati, Mojtaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220781/
https://www.ncbi.nlm.nih.gov/pubmed/35740534
http://dx.doi.org/10.3390/cancers14122868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220781/
https://www.ncbi.nlm.nih.gov/pubmed/35740534
http://dx.doi.org/10.3390/cancers14122868

Ejemplares similares